Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $2.5 million.

  • Arcadia Biosciences' Operating Expenses fell 2556.87% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 1962.89%. This contributed to the annual value of $8.7 million for FY2024, which is 1764.87% down from last year.
  • As of Q3 2025, Arcadia Biosciences' Operating Expenses stood at $2.5 million, which was down 2556.87% from $2.0 million recorded in Q2 2025.
  • Arcadia Biosciences' Operating Expenses' 5-year high stood at $16.0 million during Q4 2021, with a 5-year trough of -$674000.0 in Q2 2024.
  • Moreover, its 5-year median value for Operating Expenses was $3.5 million (2024), whereas its average is $5.0 million.
  • In the last 5 years, Arcadia Biosciences' Operating Expenses surged by 481238.94% in 2021 and then crashed by 12450.02% in 2024.
  • Arcadia Biosciences' Operating Expenses (Quarter) stood at $16.0 million in 2021, then tumbled by 66.18% to $5.4 million in 2022, then plummeted by 63.53% to $2.0 million in 2023, then surged by 77.41% to $3.5 million in 2024, then decreased by 29.79% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $2.0 million for Q2 2025, and $670000.0 during Q1 2025.